Depemokimab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Effect of depemokimab on asthma control and clinical outcomes: a systematic review and meta-analysis of randomized controlled trials.
Journal: Expert review of respiratory medicine
Published: June 10, 2026
Depemokimab: A twice yearly anti-IL 5 biologic for chronic rhinosinusitis with nasal polyps (CRSwNP) - A narrative review.
Journal: Human vaccines & immunotherapeutics
Published: June 03, 2026
Documentation of biological treatment in asthma
Journal: Pneumologie (Stuttgart, Germany)
Published: May 18, 2026
NIMBLE Did Not Establish Noninferior Switching to Depemokimab.
Journal: American journal of respiratory and critical care medicine
Published: April 05, 2026
The preclinical discovery and development of depemokimab for severe eosinophilic asthma.
Journal: Pulmonary pharmacology & therapeutics
Published: April 02, 2026
Indirect Treatment Comparison of Tezepelumab Versus Other Biologics in Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Literature Review and Network Meta-analysis.
Journal: Advances in therapy
Published: March 13, 2026
Depemokimab (Exdensur) for severe eosinophilic asthma.
Journal: The Medical letter on drugs and therapeutics
Published: March 07, 2026
How to monitor response to biologics in children with severe asthma.
Journal: Paediatric respiratory reviews
Published: March 04, 2026
Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling Study.
Journal: Journal of asthma and allergy
Published: February 27, 2026
Current and Emerging Biologic Therapies for Severe Asthma.
Journal: Drugs
Published: February 07, 2026
Depemokimab reduces asthma exacerbations similarly to other biologics: systematic trial review and indirect treatment comparison.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 26, 2026
Last Updated: 06/30/2026